"Great Lakes Medical Research is an award winning internationally respected medical research business in Westfield New York. Over the past 18years they have participated with notable pharmaceutical companies along with clinical trials at nationally recognized educational institutions. The research team is made up of certified research coordinators, principal investigators, and registered nurses who as a team have been selected by medical firms all over the world to conduct phase II, III, and IV research studies. The aim of Great Lakes Medical Research is to better inform the public of research opportunities available to them. Great Lakes Medical Research offers access to clinical trials for an array of chronic diseases."

During the past decade, Great Lakes Medical Research conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Great Lakes Medical Research" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Exact Sciences Corporation" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Great Lakes Medical Research" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Cardiokine Biopharma, LLC" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Great Lakes Medical Research" are "Cardiovascular Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Colorectal Cancer" (2 trials), "Crohn Disease" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Great Lakes Medical Research" in a lesser frequency.

Most popular intervention types in "Great Lakes Medical Research" are "Drug" (23 trials), "Procedure" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Etrasimod" (3 trials), "Dulaglutide" (2 trials), "Etrolizumab" (2 trials) and "Filgotinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Great Lakes Medical Research" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Great Lakes Medical Research". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Great Lakes Medical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Great Lakes Medical Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".